Jasper Therapeutics, Inc.·4

Oct 13, 6:58 PM ET

Mahal Jeetinder Singh 4

4 · Jasper Therapeutics, Inc. · Filed Oct 13, 2023

Insider Transaction Report

Form 4
Period: 2023-10-12
Mahal Jeetinder Singh
DirectorCEO and President
Transactions
  • Tax Payment

    Voting Common Stock

    2023-10-12$0.85/sh37,126$31,557250,097 total
Footnotes (1)
  • [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary